PT Diastika Biotekindo Tbk (IDX:CHEK)

Indonesia · Delayed Price · Currency is IDR

134.00

0.00 (0.00%)

Last updated: Sep 2, 2026, 11:10 AM WIB

IDX:CHEK Financials Overview

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	205,273	201,306	154,792	129,098	117,468
Revenue Growth	19.84%	30.05%	19.90%	9.90%	-
Gross Profit	78,030	72,982	58,046	45,956	41,178
Operating Income	17,479	19,330	19,363	12,117	13,221
Net Income	12,267	14,023	15,175	13,591	13,035
Earnings Per Share	3.04	3.41	6.04	5.41	5.19
EPS Growth	-60.29%	-43.57%	11.65%	4.26%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Clinical Diagnostics	147,705	141,858	116,985	108,147	100,665
Life Science	57,568	59,448	37,807	20,951	16,803
Total	205,273	201,306	154,792	129,098	117,468

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	46,959	68,831	18,991	21,222	23,539
Total Debt	21,586	18,281	580.35	964.8	143.05
Net Cash (Debt)	25,373	50,550	18,411	20,257	23,396
Net Cash Growth	368.13%	174.56%	-9.11%	-13.42%	-
Net Cash Per Share	6.29	12.29	7.33	8.07	9.32

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-41,008	-43,151	13,042	19,389	7,303
Capital Expenditures	-34,109	-28,219	-14,977	-16,059	-6,769
Free Cash Flow	-75,117	-71,369	-1,934	3,330	534.23
Free Cash Flow Growth	-	-	-	523.35%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	38.01%	36.25%	37.50%	35.60%	35.05%
Operating Margin	8.52%	9.60%	12.51%	9.39%	11.25%
Pretax Margin	8.11%	9.14%	12.46%	13.59%	14.27%
Profit Margin	5.98%	6.97%	9.80%	10.53%	11.10%
FCF Margin	-36.59%	-35.45%	-1.25%	2.58%	0.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	44.06	47.81	-	-	-
PS Ratio	2.63	3.33	-	-	-